Immune-system diseases
This page brings together the European Medicines Agency's (EMA) latest information on diseases affecting the immune system.
It lists the following:
- the newest and most recently updated medicines authorised for immune-system diseases in the European Union
- EMA's latest news announcements related to immune-system diseases
- EMA's events on topics related to immune-system diseases
This page includes information related to HIV and AIDS. To see information on HIV- and AIDS-related topics only, see HIV and AIDS.
We are currently unable to display the new and recently updated medicines authorised for immune-system diseases due to a technical error. We are working to resolve the issue as soon as possible. We apologise for any inconvenience caused.
Latest news
16 new medicines recommended for approval; another ten medicines recommended for extension of their therapeutic indications
25 April 2025
Five new medicines recommended for approval; another seven medicines recommended for extension of their therapeutic indications
28 March 2025
EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2024 meeting.
7 May 2024
EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its December 2023 meeting.
15 December 2023
Events of interest
Currently, we have no events for this therapeutic area.
EMA Custom Webtools Rating widget: Hidden by field_ema_hide_rating for this node.